NPF Submits Letter in Support of Washington Insulin Cap Bill SB 6087 to Senate Health & Long Term Care Committee


Numerous studies have demonstrated that individuals with psoriatic disease face a higher risk for diabetes, even when controlling for risk factors such as obesity and hypertension. By limiting the cost of insulin prescriptions to $100, E2SSB 6087 would help reduce patient costs, there by improving patient’s ability to access insulin. 

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.